Medication adherence is a complex behaviour with multiple determinants. Understanding the barriers and facilitators of adherence is invaluable for programme improvement, which assists the foundation of adherence intervention strategies. A qualitative study was conducted in six selected hospitals of Addis Ababa in 2008, to explore barriers and facilitators to antiretroviral medication adherence among HIV-infected paediatric patients. Twelve caregivers of adherent and non-adherent children and 14 key informants in five hospitals were included in the study. The findings revealed that over-dosage (heavy pill burden), fear of stigma and discrimination, cost and access to transportation, lack of understanding of the benefit of taking the medication, economic problems in the household, and lack of nutritional support were the barriers to adherence to HAART. The presence of mobile/wall alarm, the presence of follow-up counselling, improved health of the child, ART clinic setups, and disclosure of HIV serostatus were among the facilitators. This study indicated that paediatric adherence to antiretroviral therapy faces a huge challenge. It suggests the provision of income-generating schemes to caregivers for assisting HIV-infected children. Health care providers should address proper usage of medication reminders. Kebede Deribe, MPH, is a public health specialist working in a humanitarian aid organisation, FIDA, Ethiopia. He holds a Master's degree in public health and his research interests include health in humanitarian settings, migration and health, infectious disease and HIV/AIDS. He has published several journal articles.
Introduction
Worldwide, about 2.3 million children are infected with HIV, of whom nearly 90% are in sub-Saharan Africa (UNAIDS/ WHO, 2006) . In 2006 alone, new infections in children under 15 years were estimated to be 530 000 (410 000 -660 000) and there were 380 000 deaths (UNAIDS/ WHO, 2006) . It is currently estimated that 1 600 children are infected every day (UNAIDS, 2004) .
During the last few years, the introduction of highly active antiretroviral therapy (HAART) has dramatically changed the natural course of HIV infection (Hogg et al., 1998; Palella et al., 1998) .
Research indicates that consistently high levels of adherence are necessary for reliable viral suppression (Bangsberg et al., 2000; Paterson et al., 2000) , prevention of resistance , and disease progression (Bangsberg et al., 2001) .
Along with this, many factors can affect the ability of HAART to suppress viral replication, including low potency of one of the drugs in the combination, viral resistance, inadequate drug exposure and inadequate adherence to therapy. The major factor determining the success of HAART is sustained and optimum adherence to therapy (Starace, Massa, Amico, & Fisher, 2006) , as poor adherence increases the risk of virological failure and viral resistance (Nischal, Khopkar, & Saple, 2005) .
Sustaining adherence represents a significant challenge for children receiving treatment and for their caregivers. In order to facilitate adherence and improve outcome of HAART in HIVinfected children it is necessary to identify potential relevant issues in paediatric patients that influence adherence, and to determine the possible interventions to improve adherence in children (Shah, 2007) . There is a paucity of reports on HAART in children from resource-poor settings. Therefore, understanding of barriers and facilitators helps in planning interventions to address adherence concerns. The objective of this study was to explore the barriers and facilitators to HAART adherence among HIV-infected children.
Methods

Study setting
The study was conducted in selected hospitals in Addis Ababa, the capital city of the Federal Democratic Republic of Ethiopia. 
Design and participants
For this study, two population groups were chosen to be interviewed. The first group was patients who had received continuous antiretroviral therapy for the previous 12 weeks before the study in the selected hospitals, with caregivers who were parents or guardians who were counselled on the importance of drug adherence. In addition, this group needed to present for follow-up during the data collection period. In-depth interviews were undertaken with the caregivers in six selected adherent and six selected non-adherent cases of children with diverse socioeconomic and demographic characteristics (Table   1 ). Participants were eligible for the study if they expressed a willingness to share their views on adherence to ART. The second group was individuals involved in or supporting the provision of treatment and care for patients on ART. These individuals consisted of 14 key informants, eight counsellors and four physicians, including two paediatricians ( Table 2 ). Original Article
Data collection
In-depth interviews were conducted by the principal investigator with caregivers of HIV-positive children and health workers, including counsellors and paediatrician. An interview guide was used, which consisted of open-ended questions related to broad subject areas regarding: knowledge of the disease and its treatment, factors that influence adherence, personal perspectives of the medication, and barriers and facilitators of patient adherence to treatment. The interviews were conducted in a hospital setting that was convenient for key informants as well as caregivers. The level of adherence was assessed by selfreport (of the primary caregiver). Field notes were written at the conclusion of each interview and all tapes were transcribed.
Ethical clearance was obtained from Jimma University and
Addis Ababa Health Bureau. Caregivers were informed that refusing to participate in the study would not affect their access to treatment. All participants who were interviewed individually gave consent.
Data analysis
The interview data were analysed manually, using thematic content analysis. This approach is a comparative process by which the various accounts gathered are compared with each other to classify those 'themes' that recur or are common in the data set (Green, & Thorogood, 2004) . All transcripts were read several times by the investigators separately to bring out the main ideas, barriers and facilitators of adherence. Later the data were reviewed and combined into broader categories in terms of key variables; the information was then ordered, reduced and classified or coded, displayed, summarised and finally interpreted. Identification of barriers and facilitators of ART adherence were evaluated according to the principles of phenomenological analysis, in that inquiry aimed to fully describe the lived experience of those children who took antiretroviral therapy, as well as the perceptions of the caregivers on the barriers and facilitators in day-to-day life (Polit & Beck, 2004) .
Results
In this study several barriers and facilitators of paediatric adherence were identified. These factors are presented below. 
Key barriers
Caregiver factors/characteristics
Article Original
As explained by the caregivers, nutritional problems were a common barrier to patient adherence to medication regimens.
The issue of food security is a prerequisite for the initiation, as well as the continuation of the treatment. One 32-year-old male caregiver expressed this idea in few words: no food, no drug to take.
A 28-year-old female nurse counsellor from one of the hospitals stated the situation as follows:
There is no food /nutrition in the households, so the children 
Medication-related factors
Most of the caregivers and health care workers reported the high dosages (heavy pill burden), patient dislike of taking the medication, and the children spitting out the medication as causes of poor adherence to the medication regimens. Caregivers also reported that the time of administration of the prescribed drugs was conflicting with normal working hours. 
Caregivers' and health care providers' relationship
Key facilitators
Both the caregivers and health care providers reported facilitators of adherence to prescribed medication as: equipment for children to play with in hospitals; the presence of both parents alive at home with the child; the receipt of ongoing counselling to the caregivers on adherence; disclosure of the diagnosis of HIV to the child; a well-educated caregiver; and seeing the improvement in quality of life in the children. The majority of the children came to the hospital without missing their followup appointments because they felt content in the hospital setting and they were able to play with children of the same age group:
Children have an opportunity to draw a picture, paint on paper, and have a good relationship with us in this manner 
Discussion
Resource-limited settings present unique challenges to ART adherence. A multitude of structural barriers prevent access to health care and the regular supply of antiretroviral drugs. These include the cost of medical care, drugs, and the difficulty of making follow-up appointments due to long distances, family responsibilities, and the prohibitive cost of transportation (Mukherjee et al., 2006) . This finding is consistent with our findings, in that cost of transportation becomes a huge burden to the family, so the family income becomes a major barrier for sustained treatment with ART in low-income countries. Again, this is supported by a body of literature (Bangsberg , Ware, & Simoni, 2006; Byakika-Tusiime et al., 2005; Lanièce et al., 2003; Nachega et al., 2004; Weiser et al., 2003) .
Nutritional support was found to be a significant contributor to medication adherence, as lack of nutritional support at the health facilities level emerged as an important factor for ART non-adherence in our study. In similar fashion, other qualitative studies found that food security was a barrier to successful utilisation of HAART (Howland et al., 2000; Martinez et al., 2000) . This is a critical factor in implementation of an ART programme, so that it is imperative to take a look at nutritional support as a precursor to ART uptake leading to better adherence. In addition, in this study, housing instability was demonstrated as a barrier, which is consistent with Martinez et al. (2000) and Howland et al. (2000) , who identified negative life events (e.g. housing instability, poverty) and economic instability as significant factors in predicting adherence. This has important implications, as participants who could secure stability concerning financial matters were more likely to take their medication regularly.
The present study's findings suggest that HIV serostatus disclosure influences adherence to ART regimens for some HIV-positive children. This is supported by a study of HIVinfected adults, which found that the most frequent reasons for non-adherence reflected general concerns about treatment as a reminder of one's HIV status, not wanting other people to know one's HIV status, and difficulty remembering to ask health care providers questions about treatment (Catz, Kelly, Bogart, Benotsch, & McAuliffe, 2000) .This is probably due to the fear of stigma and discrimination attached to taking medication at home, as relatives or neighbours might be present at the time.
The majority of participants listed being away from home and getting holy water for themselves and their children as reasons for not providing medication. Various other studies support the finding that being away from home is a barrier to medication adherence (Laws, Wilson, Bowser, & Kerr, 2000; Ryan, & Wagner, 2003; Witteveen, & van Ameijden, 2002) . The number of medications prescribed has also been found to affect adherence (Samet et al., 1992) , which was consistent with our findings.
In our study, physician communication with patients was successful as reported by both nurse counsellors and caregivers, but problems arose in selected hospitals where physician rotation presented a potential gap between physician and
caregiver. An expanded view that takes account of this fact is that poor provider-patient relationships have an impact on adherence (Okuno, Yanagi, & Tomura, 2001 ). Article Original relevant to the developing world as there is a paucity of such studies in low-income countries (Mills, Nachega et al., 2006) .
Despite this, the study had some limitations. The findings from this study reflect the caregiver's perceptions of reported barriers and facilitators of adherence to antiretroviral therapy. The crosssectional nature of the interviews limited our ability to assess changes in adherence, while adherence is a dynamic process not to be predicted at a single point in time. A qualitative study may limit the generalisability of findings, yet be relevant for idea/ hypothesis generation concerning further research.
In conclusion, paediatric adherence to antiretroviral therapy faces huge challenges in the future. Disclosure of HIV status, food insecurity, costs of transportation, housing instability, medication factors, and patient-provider communication were
found to be of major concern among caregivers and providers.
This highlights the importance of income-generating schemes for the caregiver in assisting HIV-infected children. Also, health care providers should address proper usage of alarms and mass media for medication reminders. The health worker should stress ART drug adherence, health education should be tailored in mass media to the community, and provision of nutritional support to the caregiver should be stressed as well. Though the challenges are large, they are by no means insurmountable, and the identification of facilitators and barriers to patient medication adherence is a start in finding solutions for our paediatric patients on ART therapy.
